Inventor · disambiguated record
Stefan Abele
Also filed as: ABELE STEFAN
15 granted patents·2 pending applications·56 citations·filing 2007–2023
89Inventor score
Files withACTELION PHARMACEUTICALS LTD6ABELE STEFAN5IDORSIA PHARMACEUTICALS LTD2VISTAGEN THERAPEUTICS INC2BOSCH GMBH ROBERT1
Top patents by PatentIndex Score
17 records- 0193US8912340B2Process for the preparation of 2-imino-thiazolidin-4-one derivativesABELE STEFAN·Filed 2012·Granted Dec 16, 2014·16 cites·19 claims
- 0291US8263780B2Process for the preparation of 2-imino-thiazolidin-4-one derivativesABELE STEFAN·Filed 2007·Granted Sep 11, 2012·25 cites·4 claims
- 0383US9938244B2Process for manufacturing pyrimidine sulfamide derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Apr 10, 2018·7 cites·21 claims
- 0475US9834801B2Methods for the synthesis of chiral kynurenine compoundsVISTAGEN THERAPEUTICS INC·Filed 2014·Granted Dec 5, 2017·2 cites·16 claims
- 0573US10899695B2Process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanesIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Jan 26, 2021·1 cites·17 claims
- 0673US9422249B2Preparation of pyrimidine intermediates useful for the manufacture of macitentanACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Aug 23, 2016·1 cites·15 claims
- 0770US8816118B2Diastereoselective preparation of bicyclo[2.2.2]octan-2-one compoundsABELE STEFAN·Filed 2011·Granted Aug 26, 2014·1 cites·20 claims
- 0870US8492555B2Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl esterABELE STEFAN·Filed 2009·Granted Jul 23, 2013·2 cites·13 claims
- 0961US9127002B2Process for manufacturing a naphthyridine derivativeACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Sep 8, 2015·0 cites·8 claims
- 1058US11338849B2Method for analyzing and/or at least partially compensating steering wheel torsional vibrationsBOSCH GMBH ROBERT·Filed 2018·Granted May 24, 2022·1 cites·16 claims
- 1157US10294502B2Methods for the synthesis of chiral kynurenine compoundsVISTAGEN THERAPEUTICS INC·Filed 2017·Granted May 21, 2019·0 cites·6 claims
- 1257US9187476B2Process for manufacturing naphthyridine derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Nov 17, 2015·0 cites·15 claims
- 1356US2025197904A1A process for the synthesis of ( r)-2-(( tert-butoxycarbonyl)amino)-3-(diethoxyphosphoryl)propanoic acid or of phosphonate derivatives thereofVIATRIS ASIA PACIFIC PTE LTD·Filed 2023·Application pending·0 cites
- 1455US9676731B2Preparation of pyrimidine intermediates useful for the manufacture of macitentanACTELION PHARMACEUTICALS LTD·Filed 2016·Granted Jun 13, 2017·0 cites·5 claims
- 1552US9556125B2Process for preparing a pyrimidine intermediateACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jan 31, 2017·0 cites·12 claims
- 1649US2015336954A1Process for Manufacturing a Naphthyridine DerivativeACTELION PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 1741US9296673B2Preparation of bicyclo[2.2.2]octan-2-one compoundsABELE STEFAN·Filed 2011·Granted Mar 29, 2016·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →